CoChat

Benzodiazepines and anxiety disorders: a review for the practicing physician

Kaplan, Eric Michael, DuPont, Robert L. · 2005 · Current Medical Research and Opinion

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Abstract

UNLABELLED: OBJECTIVES AND SCOPE: The objective of this article is to briefly review for practicing clinicians differences among the benzodiazepines (BZDs) that are commonly used to treat anxiety, the efficacy of BZDs in various anxiety disorders, and potential safety issues associated with BZDs, including adverse events, tolerance, dependence, and withdrawal. METHODOLOGY: Information for this review was obtained using literature searches through PubMed (1966-2004), Google, and the Food and Drug Administration Catalog of Approved Drugs. Data sources were searched for information regarding anxiety disorders and the safety and efficacy of BZDs. Wherever possible and appropriate, information from randomized controlled trials was given priority. FINDINGS: Benzodiazepines have demonstrated efficacy in treating patients with anxiety disorders, with varying degrees of efficacy. Use of BZDs is advantageous because they have a quick onset of action and are generally well tolerated. Extended-release formulations of BZDs may be particularly advantageous in some patients with anxiety as they allow for maximization of a drug's therapeutic window with consistent serum drug concentrations. CONCLUSIONS: BZDs remain a mainstay in the treatment of anxiety, as both monotherapy and adjunctive therapy. Factors to consider prior to prescribing a BZD include the patient's diagnosis, as well as drug characteristics, including the potential for interactions with other drugs, the risk of dependence and withdrawal, and the required frequency of dosing.

Overview

Integrity signals

Registry

Crossref · 10.1185/030079905x48401

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 106 references

Research works printed but not linked: 9

  1. Rochiccioli P. Use of an anxiolytic agent: clobazam in children [in French]. Rev Int Pediatr 1977;59–62
  2. Disayavanish C Mahatnirunkul S Disayavanish P. Differential effects of three benzodiazepines in the treatment of neurotic patients. In: Hindmarch I Stonier PD Trimble M editors. Clobazam: Human Psychopharmacology and Clinical Applications. London: The Royal Society of Medicine; 1985. pp.81–8
  3. Harrison C Hindmarch I Clyde CA. A comparison of clobazam and diazepam in anxious patients. In: Hindmarch I Stonier PD Trimble M editors. Clobazam: Human Psychopharmacology and Clinical Applications. London: The Royal Society of Medicine; 1985. pp.89–100
  4. Thompson DJ. Comparison of drug treatment (clobazam) and relaxation therapy in the management of anxiety. Preliminary communication. In: Hindmarch I Stonier PD Trimble M editors. Clobazam: Human Psychopharmacology and Clinical Applications. London: The Royal Society of Medicine; 1985. pp.101–3
  5. DuPont RL, DuPont CM, DuPont Spencer E. Generalized anxiety disorder: a clinician’s guide to “the worry disease”. Dir Psychiatry 1999;XIX:133–45
  6. Siegfried K, Koeppen D, Taeuber K, Badian M, Malerczyk V, Sittig W. A double-blind comparison of the acute effects of clobazam and lorazepam on memory and psychomotor functions. Royal Soc Med Int Symp Ser 1981;43:13–21
  7. DuPont RL DuPont Spencer E DuPont CM. Anxiety and insomnia. In: The Anxiety Cure. An Eight-Step Program for Getting Well. Hoboken NJ: John Wiley & Sons; 2003. pp.200–6
  8. Kirkwood CK Melton ST. Anxiety disorders. In: Dipiro JT Talbert RL Yee GC Matzke GR Wells BG Posey LM editors. Pharmacotherapy: A Pathophysiologic Approach. 5th edn. Chicago: McGraw-Hill; 2002. pp.1289–310
  9. DuPont RL DuPont CM. Sedatives/hypnotics and benzodiazepines. In: Frances RJ Miller SI editors. Clinical Textbook of Addictive Disorders. New York: The Guilford Press; 1998. pp.120–49

Cited by

See all 59

Metadata

Authors
Kaplan, E. M., & DuPont, R. L.
Affiliations
  • University of South Florida (US)
  • Georgetown University (US)
Corresponding author
Kaplan, Eric Michael
Venue
Current Medical Research and Opinion
Published
2005-05-12
Volume
21
Issue
6
Pages
941-950
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W2137986275
Cited by
55
References
106
Citations by year
2025: 3 · 2024: 2 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 2 · 2012: 5
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medical Research and Opinion (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
Keywords
benzodiazepines, anxiety disorders, drug tolerance, benzodiazepine dependence, benzodiazepine withdrawal, sustained-release formulation, drug interactions
MeSH terms
Anxiety Disorders, Benzodiazepines, Drug Tolerance, Humans, Practice Patterns, Physicians', Substance Withdrawal Syndrome, Anti-Anxiety Agents, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benzodiazepines and anxiety disorders: a review for the practicing physician. https://app.cochat.ai/papers/10.1185/030079905x48401
The paper
Kaplan, E. M., & DuPont, R. L. (2005). Benzodiazepines and anxiety disorders: a review for the practicing physician. Current Medical Research and Opinion. https://doi.org/10.1185/030079905x48401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.